http://rdf.ncbi.nlm.nih.gov/pubchem/patent/YU-68702-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_757c3a30eee57315f364b0563b0ecea6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-04
filingDate 2001-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98998aa49eccf5b9c603b6c123a3242c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cd8b481f769071c6971da3b8190985a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_096f8997e2c4554fb192f60ba2afcfa6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d02de84cf051e3313869c0ccadde27d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84ff4bf61aeeae8d233e13b32d294ac8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9f7087213d1dea4746a33e5b3470da2
publicationDate 2006-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber YU-68702-A
titleOfInvention NEW LHRH ANTAGONISTS, THEIR PRODUCTION AND USE AS A MEDICINE
abstract The invention relates to peptides, which comprise an N-methylated amino acid component and improved water solubility. According to the invention, medicaments containing said peptides can be used to treat hormone-dependent tumors and non-malignant hormone-induced diseases. [The invention relates to peptides, comprising an N-methylated amino acid component and an improved water solubility. According to the invention, medicaments containing the said peptides can be used for the treatment of hormone-dependent tumors and hormone-influenced non-malignant disease states.
priorityDate 1999-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Total number of triples: 31.